F-fdg pet imaging in assessing exudative pleural effusions

Nuclear Medicine Communications

Volumn 27, Issue 12, 2006, Pages 971-976

  Duysinx, Bernard C ^a   Larock, Marie Paule ^b   Nguyen, Delphine ^a   Corhay, Jean Louis ^a   Bury, Thierry ^a   Hustinx, Roland ^a   Louis, Renaud ^a  

^a Divisions of Pulmonary Medicine   (Belgium)

^b UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Cancer; Fluorodeoxyglucose; Pleural effusion; Positron emission tomography

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GLUCOSE;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BENIGN TUMOR; BODY SURFACE; BODY WEIGHT; CANCER DIAGNOSIS; CLINICAL ASSESSMENT; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; EVALUATION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; LEAN BODY WEIGHT; LUNG CANCER; LUNG TUMOR; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MESOTHELIOMA; PATHOLOGY; PLEURA CANCER; PLEURA EFFUSION; PLEURA FLUID; PLEURA METASTASIS; PLEURISY; POSITRON EMISSION TOMOGRAPHY; QUANTITATIVE ANALYSIS; RECEIVER OPERATING CHARACTERISTIC; STANDARD; STATISTICAL SIGNIFICANCE; THORACOSCOPY;

EXUDATES AND TRANSUDATES; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; PLEURAL EFFUSION; PLEURAL NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 33750741108     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/01.mnm.0000243366.96012.c0     Document Type: Article

References (27)

1. Dedrick C, McLoud T, Shepard J, Shipley RT. Computed tomography of localized pleural mesothelioma. AJR Am J Roentgenol 1985; 144:275-280.
2. Leung A, Muller N, Miller R. CT in differential diagnosis of diffuse pleural disease. AJR Am J Roentgenol 1990; 154:487-492.
3. Sahn S. Malignant pleural effusions. In: Fischman AP (editor): Pulmonary diseases and disorders, 2nd edition. New York: McGraw-Hill; 1988, pp. 2159-2170.
4. Sahn S. State of the art: the pleura. Am Rev Resp Dis 1988; 138:184-234.
5. Prakash U, Reiman H. Comparison of needle biopsy with cytologic analysis for the évaluation of pleural effusion: analysis of 414 cases. Mayo Clin Proc 1985; 60:158-164.
6. Von Hoff D, Di Volsi V. Diagnostic reliability of needle biopsy of the parietal pleura: a review of 272 biopsies. Am J Clin Pathol 1979; 72:48-51.
7. Schönfeld N, Loddenkemper R. Pleural biopsy and thoracoscopy. Eur Respir Mon 1998; 9:135-152.
8. Poe R, Israel R, Utell M, Hall WJ, Greenblatt DW, Kallay MC. Sensitivity, specificity and predictive values of closed pleural biopsy. Arch Intern Med 1984; 144:325-328.
9. Hughes J, Brudin L, Valind S, Rhodes CG. Positron emission tomography in lung. J Thorac Imaging 1985; 1:78-88.
10. 18F-FDG-PET imaging: preliminary report. Thorax 1997; 52:187-189.
11. Belhocine TZ, Daenen F, Duysinx B, Bury T, Rigo P. Typical appearance of mesothelioma on an F-18 FDG positron emission tomograph. Clin Nucl Med 2000; 25:636.
12. Benard F, Sterman D, Smith R, Kaiser LT, Albelda SM, Alavi A. Metabolic imaging of malignant pleural mesothelioma with fluorodeoxyglucose positron emission tomography. Chest 1998; 114:713-722.
13. 18F-FDG PET imaging in malignant pleural mesothelioma. J Nucl Med 2000; 41:1443-1444.
14. Carretta A, Landoni C, Melloni G, Ceresoli GL, Compierchio A, Fazio F, Zannini P. 18-FDG positron emission tomography in the evaluation of malignant pleural diseases - a pilot study. Eur J Cardiothorac Surg 2000; 17:377-383.
15. Gupta N, Rogers J, Graeber G, Gregory JL, Waheed U, Mullet D, Atkins M. Clinical role of F-18 fluorodeoxyglucose positron emission tomography imaging in patients with lung cancer and suspected malignant pleural effusion. Chest 2002; 122:1918-1924.
16. 18F-FDG PET. Radiology 2004; 231:858-865.
17. 18F-fluorodeoxyglucose positron emission tomography imaging. Chest 2004; 125:489-493.
18. Erasmus J, McAdams HP, Rossi SE, Goodman PC, Coleman RE, Patz EF. FDG PET of pleural effusions in patients with non-small cell lung cancer. AJR Am J Roentgenol 2000; 175:245-249.
19. Kramer H, Pieterman M, Slebos DJ, Timens W, Vaalburg W, Koeter GH, Groen HJ. PET for the evaluation of pleural thickening observed on CT. J Nucl Med 2004; 45:995-998.
20. Haberkorn U. Positron tomography in the diagnosis of mesothelioma. Lung cancer 2004; 455:S73-S76.
21. Light RW, Macgregor MI, Luchsinger PC, Ball Jr WC. Pleural effusions: the diagnositic of transudates and exsudates. Ann Intern Med 1972; 77:507-513.
22. Light RW, Erozan YS, Ball WC. Cells in pleural fluid. Their value in differential diagnosis. Arch Intern Med 1973; 132:854-860.
23. Du Bois D, Du Bois EF. A formula to estimate the approximate surface area if height and weight be known. Nutrition 1989; 5:303-311; discussion 312-313. (A reprint of the article originally published in 1916.)
24. Sugawara Y, Zasadny KR, Neuhoff AW, Wahl RL. Reevaluation of the standardized uptake value for FDG: variations with body weight and methods for correction. Radiology 1999; 213:521-525.
25. Menda Y, Bushnell DL, Madsen MT, McLaughlin K, Kahn D, Kernstine KH. Evaluation of various corrections to the standardized uptake value for diagnosis of pulmonary malignancy. Nucl Med Commun 2001; 22:1077-1081.
26. Delong ER, Delong DM, Clarke Pearson DL. Comparing the area under two or more correlated receiving operating characteristics curves. A non parametric approach. Biometrics 1988; 44:837-845.
27. Dwamena BA, Sonnad SS, Angobaldo O, Wahl RL. Metastases from non-small cell lung cancer: mediastinal staging in the 1990s - a meta-analytical comparison of PET and CT. Radiology 1999; 213:530-536.